Craig Falls

Orrick, Herrington & Sutcliffe LLP

+ Follow Contact

Latest Posts › Food and Drug Administration (FDA)

Share:

Life Sciences Snapshot – Q4 2024 – A Quarterly Report on Financing Trends

Since the previous quarter’s Life Sciences Snapshot, robust dealmaking activity in Q3 has launched YTD life sciences VC deal activity to near parity with 2023 figures, firmly positioning 2024 as the year to break the two-year...more

12/23/2024 / Biotechnology , Food and Drug Administration (FDA) , Life Sciences , Medical Devices , Pharmaceutical Industry , Prescription Drugs

Life Sciences and Health Care Companies Under the Competition Microscope: New Cross-Government Initiatives Seek to Expose...

U.S. antitrust enforcers launched a flurry of initiatives in the first half of 2024 to identify and prevent antitrust and other violations in life sciences and health care. Among these are two cross-agency Requests for...more

7/10/2024 / Department of Health and Human Services (HHS) , Department of Justice (DOJ) , Federal Trade Commission (FTC) , Food and Drug Administration (FDA) , Hart-Scott-Rodino Act , Life Sciences , Mergers

Life Sciences Snapshot – Q2 2024 – A Quarterly Report on Financing Trends

This report series examines quarterly trends in life sciences venture investment. Key findings for Q1 2024 include: • Life sciences VC deal value in Q1 totaled $7.8 billion, which represents a 22.1% increase in value from Q4...more

6/27/2024 / Clinical Trials , Food and Drug Administration (FDA) , Life Sciences , Medical Devices , Pharmaceutical Industry , Prescription Drugs

3 Results

View per page

Page: of 1